News-Medical.Net on MSN
Syndex Bio unveils mcPCR technology at AGBT 2026 following $15.5 M seed financing
Syndex Bio, a biotechnology company advancing next‑generation molecular diagnostics, today announced the introduction of its proprietary mcPCR ™ (methyl‑copying PCR) platform at the Advances in Genome ...
Takara Bio USA, Inc. ("Takara Bio USA"), a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), today announced a series of updates to its spatial biology product portfolio, extending its ...
Artis BioSolutions (“Artis”), a San Diego-based advanced-therapies development and manufacturing company, today announced that it has entered into a definitive agreement to acquire Syngoi Technologies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results